In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients.

Host

Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Daniel Gil, CEO, Pelage Pharmaceuticals

Francisco Ramírez-Valle, Senior Vice President, Immunology Discovery, Eli Lilly

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.